Labetalol is frequently chosen over pure beta-blockers for hypertensive emergencies in pregnancy. The pharmacological property responsible for this preference is:

• A Combined nonselective beta blockade and alpha-1 blockade, reducing peripheral resistance while preserving uteroplacental blood flow ✓
• B Selective beta-1 antagonism without any vascular effect
• C Direct arterial smooth muscle relaxation through calcium channel blockade
• D Central alpha-2 agonism that suppresses sympathetic outflow

Explanation

Labetalol blocks both beta receptors (nonselectively) and alpha-1 receptors, so it lowers blood pressure by decreasing peripheral vascular resistance while the beta component limits the reflex tachycardia that pure vasodilators provoke. This balanced profile maintains uteroplacental perfusion, which matters in preeclampsia. Option B describes metoprolol-like selectivity, which labetalol lacks. Option C describes a dihydropyridine, and option D describes clonidine or methyldopa, whose central effects differ from labetalol's peripheral dual blockade.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.